A note on the nature of utility in time and health and implications for cost utility analysis

被引:14
|
作者
Buckingham, Ken J. [2 ]
Devlin, Nancy Joy [1 ]
机构
[1] City Univ London, Dept Econ, London EC1 V OHB, England
[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
关键词
Time Trade-Off (TTO); Utility; QALYs; Cost utility analysis; Maximal endurable time; QUALITY-OF-LIFE; EXTRA-WELFARISM; STATES WORSE; TRADE-OFF; PREFERENCES; VALUATIONS; VALIDITY; QALYS; DEATH; MODEL;
D O I
10.1016/j.socscimed.2008.09.048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Time Trade-Off (TTO) valuations of health are widely used in economic evaluation of health care. Current approaches to eliciting TTO values, and their use in economic evaluation, rest on specific assumptions about the way utility relates to time and health. Both the assumptions themselves and evidence of violations of them are discussed in the literature - yet the issues appear not to be widely appreciated by those using and applying TTO in economic evaluation. This paper adds to that literature by demonstrating both the requirements of TTO and violations of these assumptions in terms of the underlying indifference curve maps and utility functions. The advantage of this approach is that it demonstrates very clearly a number of fundamental problems for the way TTO values are currently elicited and used in cost utility analysis. In essence, it is extremely unwise to assume that the current 'tariffs' of TTO values, such as those widely used in cost utility analysis to inform health sector decisions in many countries can be applied irrespective of the duration of the health states to which they are assigned. The estimates of QALYs that result will, quite often, simply be wrong. We conclude by pointing to a number of possible solutions. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 50 条
  • [1] Commentary: Implications and limitations of cost-utility analysis
    Wong, David A.
    SPINE JOURNAL, 2012, 12 (08): : 691 - 692
  • [2] Cost-utility analysis in depression: The McSad utility measure for depression health states
    Bennett, KJ
    Torrance, GW
    Boyle, MH
    Guscott, R
    PSYCHIATRIC SERVICES, 2000, 51 (09) : 1171 - 1176
  • [3] Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis
    Grosse, Scott D.
    Chaugule, Shraddha S.
    Hay, Joel W.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (02) : 267 - 283
  • [4] Assessing Health Gains: A Cost-Utility Analysis
    Guarducci, G.
    Siragusa, C.
    Gurnari, J.
    Gentile, A. M.
    Nante, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [5] Preferences for health outcomes and cost-utility analysis
    Torrance, GW
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S8 - S20
  • [6] The use of health utility in cost-utility analysis: A systematic review in substance use disorders
    Tran, Anh Dam
    Zhan, Xin
    Vinzent, Annaelle
    Flood, Lorelie
    Bai, Tian
    Gallagher, Erinn
    Zaric, Gregory S.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 133
  • [7] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [8] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [9] COST UTILITY ANALYSIS IN CHILD HEALTH: WILL THE GROWTH SPURT BE SUSTAINED?
    Ungar, W. J.
    Zur, R. M.
    Costa, S.
    Kromm, S.
    Burnett, H. F.
    VALUE IN HEALTH, 2014, 17 (03) : A159 - A159
  • [10] DISCREPANCY IN HEALTH STATE UTILITY VALUES BETWEEN COST-UTILITY ANALYSIS AND REFERENCED ORIGINAL HEALTH UTILITY STUDIES IN CARDIOVASCULAR DISEASE: A REGISTRY-BASED ANALYSIS
    Zhou, T.
    Chen, Z.
    Li, H.
    Xie, F.
    VALUE IN HEALTH, 2019, 22 : S922 - S922